Stock Scorecard



Stock Summary for Celularity Inc - Class A (CELU) - $3.02 as of 4/26/2024 9:02:32 PM EST

Total Score

7 out of 29

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for CELU

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for CELU

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for CELU

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for CELU

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for CELU

Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing 4/19/2024 9:30:00 PM
Celularity Abstract "Emerging Technologies for the Management and Protection of Tendon Injuries: Decellularized Placental Biomaterials" Accepted at ORS Tendon Conference 2024 - Celularity ( NASDAQ:CELU ) , Celularity ( NASDAQ:CELUW ) 4/18/2024 8:30:00 PM
Celularity Abstract "Emerging Technologies for the Management and Protection of Tendon Injuries: Decellularized Placental Biomaterials" Accepted at ORS Tendon Conference 2024 4/18/2024 8:30:00 PM
Kuehn Law Encourages Investors of Celularity Inc. to Contact Law Firm - Celularity ( NASDAQ:CELU ) 3/22/2024 5:24:00 PM
Celularity Submits Request to U.S. FDA for Orphan Drug Designation for PDA-002 Asset Treating Facioscapulohumeral Muscular Dystrophy 3/20/2024 1:15:00 PM
Celularity CEO to Present on Cell Therapy's Potential to Improve Longevity at 2024 ABUNDANCE Summit - Celularity ( NASDAQ:CELU ) , Celularity ( NASDAQ:CELUW ) 3/14/2024 1:15:00 PM
Celularity CEO to Present on Cell Therapy's Potential to Improve Longevity at 2024 ABUNDANCE Summit 3/14/2024 1:15:00 PM
Celularity CEO to Present Keynote Address at 2024 Society for Brain Mapping and Therapeutics Annual World Congress - Celularity ( NASDAQ:CELU ) , Celularity ( NASDAQ:CELUW ) 3/12/2024 1:20:00 PM
Celularity CEO to Present Keynote Address at 2024 Society for Brain Mapping and Therapeutics Annual World Congress 3/12/2024 1:20:00 PM
Celularity to Present Data Showing Cancer Tumor Reduction by Off-the-Shelf Cell Therapy Derived from Human Placental Cells - Celularity ( NASDAQ:CELU ) , Celularity ( NASDAQ:CELUW ) 3/7/2024 2:35:00 PM

Financial Details for CELU

Company Overview

Ticker CELU
Company Name Celularity Inc - Class A
Country USA
Description N/A
Sector Name REAL ESTATE & CONSTRUCTION
Industry Name BLANK CHECKS
Most Recent Quarter 12/31/2023
Next Earnings Date 6/13/2024

Stock Price History

Last Day Price 3.02
Last Day Price Updated 4/26/2024 9:02:32 PM EST
Last Day Volume 49,024
Average Daily Volume 56,049
52-Week High 8.90
52-Week Low 1.59
Last Price to 52 Week Low 89.94%

Valuation Measures

Trailing PE N/A
Industry PE 86.53
Sector PE 64.69
5-Year Average PE -686.95
Free Cash Flow Ratio 302.00
Industry Free Cash Flow Ratio 263.47
Sector Free Cash Flow Ratio 172.38
Current Ratio Most Recent Quarter 0.19
Total Cash Per Share 0.01
Book Value Per Share Most Recent Quarter 1.56
Price to Book Ratio 2.21
Industry Price to Book Ratio 3.03
Sector Price to Book Ratio 3.49
Price to Sales Ratio Twelve Trailing Months 4.52
Industry Price to Sales Ratio Twelve Trailing Months 0.54
Sector Price to Sales Ratio Twelve Trailing Months 3.47

Share Statistics

Total Shares Outstanding 21,782,900
Market Capitalization 65,784,358
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Dividend Aristocrat? False
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY -92.50%
Annual Earnings Growth 114.18%
Reported EPS 12 Trailing Months -10.30
Reported EPS Past Year 0.00
Reported EPS Prior Year -1.68
Net Income Twelve Trailing Months -181,408,000
Net Income Past Year 14,192,000
Net Income Prior Year -100,118,000
Quarterly Revenue Growth YOY -8.40%
5-Year Revenue Growth -5.27%

Balance Sheet

Total Cash Most Recent Quarter 273,000
Total Cash Past Year 13,966,000
Total Cash Prior Year 37,240,000
Net Cash Position Most Recent Quarter -16,754,000
Net Cash Position Past Year 13,966,000
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 17,027,000
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 0.64
Total Stockholder Equity Past Year 198,901,000
Total Stockholder Equity Prior Year 99,418,000
Total Stockholder Equity Most Recent Quarter 30,247,000

Options

Put/Call Ratio 99.00
Has Options Options Chain
Liquidity Rating None

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.50
MACD Signal -0.33
20-Day Bollinger Lower Band 1.21
20-Day Bollinger Middle Band 3.86
20-Day Bollinger Upper Band 6.52
Beta 0.30
RSI 37.42
50-Day SMA 3.97
200-Day SMA 51.56

System

Modified 4/26/2024 8:58:53 PM EST